Multiple Long‐Term Conditions, Co‐Long‐Term Conditions and Polyvascular Disease: Considerations for Evidence Synthesis and Meta‐Analyses

Cochrane's scientific strategy for 2025 to 2030 has four research priorities, including improving the lives of people living with multiple chronic conditions. The purpose of this article written by the Cochrane Thematic Group in Heart, Stroke and Circulation is to explore considerations around multiple chronic conditions (also referred to as 'multiple long-term conditions' i.e. two or more long-term conditions) in systematic reviews. Rather than using the term 'comorbidity', we introduce a new term 'co-long-term conditions'. We also explore how to define 'polyvascular disease'. We suggest that review authors consider co-long-term conditions and multiple long-term conditions in their reviews e.g. extract data about how primary studies address co-long-term conditions, perform subgroup analyses according to presence or not of co-long-term conditions, and include a section in the discussion about how well participants with co-long-term conditions were represented in the primary studies. This is especially pertinent for reviews addressing heart, circulatory or stroke disease, and polyvascular disease.

Authors

Institutions

Publication Details

Journal
Cochrane Evidence Synthesis and Methods
Published
2025-04-03
DOI
https://doi.org/10.1002/cesm.70027
Citations
1
Primary Topic
Chronic Disease Management Strategies
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multiple Long‐Term Conditions, Co‐Long‐Term Conditions and Polyvascular Disease: Considerations for Evidence Synthesis and Meta‐Analyses

Gerard Stansby, Alex Todhunter‐Brown, Jackie F. Price, Atsushi Mizuno et al.
1 citations
Cochrane Evidence Synthesis and Methods
Chronic Disease Management Strategies
1.35
article

Multiple Long‐Term Conditions, Co‐Long‐Term Conditions and Polyvascular Disease: Considerations for Evidence Synthesis and Meta‐Analyses

Gerard Stansby, Alex Todhunter‐Brown, Jackie F. Price, Atsushi Mizuno, Jaya Singh Kshatri, Leon Flicker, Valery L. Feigin, Sanghamitra Pati, David Williams, Juan Erviti, Simiao Wu, Ukachukwu Okoroafor Abaraogu, Rui Providência, Gillian Elizabeth Mead, James M Wright, Arohi Chauhan, Amanda Barugh, Rod Stephen Taylor
article en
1 citations

Abstract

Cochrane's scientific strategy for 2025 to 2030 has four research priorities, including improving the lives of people living with multiple chronic conditions. The purpose of this article written by the Cochrane Thematic Group in Heart, Stroke and Circulation is to explore considerations around multiple chronic conditions (also referred to as 'multiple long-term conditions' i.e. two or more long-term conditions) in systematic reviews. Rather than using the term 'comorbidity', we introduce a new term 'co-long-term conditions'. We also explore how to define 'polyvascular disease'. We suggest that review authors consider co-long-term conditions and multiple long-term conditions in their reviews e.g. extract data about how primary studies address co-long-term conditions, perform subgroup analyses according to presence or not of co-long-term conditions, and include a section in the discussion about how well participants with co-long-term conditions were represented in the primary studies. This is especially pertinent for reviews addressing heart, circulatory or stroke disease, and polyvascular disease.

Cochrane Evidence Synthesis and MethodsVol. 3(3)
University of Nigeria (NG), The University of Western Australia (AU), Glasgow Caledonian University (GB), Sichuan University (CN), Freeman Hospital (GB), Indian Council of Medical Research (IN), Auckland University of Technology (NZ), St. Luke's International Hospital (JP), West China Hospital of Sichuan University (CN), Regional Medical Research Centre (IN), Navarre Institute of Health Research (ES), Asian Institute of Public Health (IN), University College London (GB), University of Glasgow (GB), University of the West of Scotland (GB), University of Edinburgh (GB)
Openalex Percentile: Top 21%
Chronic Disease Management Strategies
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.